Compare GAB & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GAB | UROY |
|---|---|---|
| Founded | 1986 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | N/A | 2026 |
| Metric | GAB | UROY |
|---|---|---|
| Price | $5.62 | $4.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 666.2K | ★ 2.4M |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | ★ 10.91% | N/A |
| EPS Growth | N/A | ★ 825.00 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $186,807,000.00 |
| Revenue This Year | N/A | $279.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.52 |
| Revenue Growth | N/A | ★ 1565.99 |
| 52 Week Low | $5.28 | $2.56 |
| 52 Week High | $6.37 | $5.52 |
| Indicator | GAB | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 61.03 |
| Support Level | $5.60 | $3.54 |
| Resistance Level | $5.72 | $4.48 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 6.00 | 49.14 |
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.